Login

Interview with John Lai, CEO & President of PetVivo Holdings, Inc., highlighting company insights and future plans. 00:10:00

Share On Facebook Share On Twitter

John Lai is Pres/CEO/IR/Co-Founder, Petvivo Holdings Inc.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
IMDEX CEO Discusses Financial Growth and Impact of DEO Acquisition
00:10:00
Alexandre Birman on Tax Reform Optimism and the Power of Company Culture | Alexandre Birman, CEO, Arezzo Industria e Comercio SA.
00:10:00
DeMarcus Testimonial: Heartland Express Driving in the Northwest | Michael J Gerdin - CHAIRMAN AND CEO of Heartland Express, Inc.
00:10:00
Data#3 & Cisco's Award-Winning Partnership | Brad Colledge, CEO, Data#3 LtdDTL:ASX
00:10:00
Peter Platzer, CEO of Spire Global, discusses Spire's space mission and their innovative "Space as a Service" platform with Judy Shaw on #NYSEFloorTalk.
00:10:00
Tom Lydon interviews David Mazza, Head of ETF Investment Strategy at State Street Global Advisors, exploring insights into ETF investment strategies.|Yie-Hsin Hung is president and chief executive officer of State Street Global Advisors
00:10:00
Empowering Women Lawyers: The Women’s Initiative Committee at S&C | William Nelson Cromwell - American attorney & Founder of Sullivan & Cromwell LLP
00:10:00
CEO of a real estate firm discusses recent capital raises and investment strategies, highlighting opportunities and challenges in Mexico's market | Jorge Avalos Carpinteyro, CEO, Fibra Mty SAPI de CV.
00:10:00
Bradesco's Digital Evolution: Pioneering Tech Integration for Enhanced Customer Experience | Marcelo Noronha, CEO, Banco Bradesco S.A.
00:10:00
Vendetta Mining Presentation Highlights
00:10:00
Building Relationships and Elevating Communication: Insights from Mark Barragan | Estrada Strategies Interview
00:10:00
John Doerr Discusses 'Measure What Matters' and the Future of Tech and Healthcare | John Doerr, Chairman,  Kleiner Perkins.

© 2026 Nehu